Skip to main content

Table 2 Clinical Laboratory Determinations

From: Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study

Screening tests Additional tests in participants with CKD
Blood/Serum
Complete Blood Cell Count (including Hemoglobin and Hematocrit) Magnesium
Hemoglobin A1C Lead
C-peptide Parathyroid Hormone
Insulin Vitamin D, 25-Hydroxy
Full non-fasting lipid panel  
Renal Function Panel: sodium, potassium, chloride, carbon dioxide, glucose (random/non-fasting), blood urea nitrogen, creatinine, albumin, phosphorus  
Uric Acid  
High Sensitivity C-reactive Protein  
Cystatin C  
Βeta 2 Microglobulin  
Urine
Automated Urinalysis Urine Urea Nitrogen
Urine Creatinine Urine Electrolytes: Sodium, Potassium, Chloride, Calcium, Phosphorus, and Magnesium
Urine Albumin and Total Protein Urine Uric Acid